Effects of Chlorella Vulgaris in improving of symptoms of silicosis

Effect of Chlorella Vulgaris complementary therapy in improving symptoms and pulmonary function test measures in patients with silicosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015010720592N1

Enrollment

Registered

2015-04-20

Start date

2011-01-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

silicosis. Pneumoconiosis due to other dust containing silica

Interventions

Intervention 1: In intervention group , In addition to standard therapy, 9 Algomed tablets daily for eight weeks. Intervention 2: Control Group: Standarad treatment (Bronchodilator).

Treatment - Drugs

In intervention group , In addition to standard therapy, 9 Algomed tablets daily for eight weeks

Control Group: Standarad treatment (Bronchodilator)

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Signs and symptoms of severe, chronic and complicated forms of silicosis; Age between 18 to 75. Exclusion criteria: Having heart disease; Forced Expiratory Volume and Therapeutic Lifestyle Changes less than 40 percent; Non-cooperation during Pulmonary Function Tests; Ptients with the history of hospitalization due to the disease exacerbations during the past three months; Tuberculosis infection; Body Mass Index more than 30

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of attacks. Timepoint: at the start of the study and after 2 months. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mohammad reza Hashemian

Masih daneshvari hospital

smrhashemian@sbmu.ac.ir+98 21 2610 9512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026